“Do Intel Numbers Even Matter at This Point?” Intel Stock (NASDAQ:INTC) Notches Up as Analysts Consider Ahead of Earnings

Intel's upcoming earnings report is largely overshadowed by investor focus on its future turnaround under new CEO Lip-Bu Tan, despite analysts forecasting Q2 revenue of $11.93 billion, a 7% year-over-year decline, and $0.02 EPS. Concerns include potential multi-billion dollar write-offs from a rumored foundry node change, while Wall Street maintains a "Hold" consensus with an average price target of $21.74, implying further downside after recent share price losses.

Analysis

Investor focus on Intel (INTC) has largely shifted from its current financial performance to its long-term turnaround strategy under new CEO Lip-Bu Tan, who took charge in March. This sentiment is underscored by analyst expectations for the upcoming earnings report, which project a 7% year-over-year revenue decline to $11.93 billion and a slight drop in adjusted net income to $74.5 million, both translating to $0.02 per share. The market appears to have priced in these weak results, as reflected by the stock's 30.78% loss over the past year. A significant point of uncertainty for the future outlook is a potential strategic shift in the foundry division, specifically abandoning the 18A node for the 14A node, which could trigger multi-billion dollar technology write-offs. This forward-looking narrative, coupled with current performance challenges, is reflected in the prevailing Wall Street consensus, which stands at a 'Hold' with an average price target of $21.74, suggesting a 6.82% downside from current levels.

Key Decisions for Investors

• Investors should prioritize management's forward-looking guidance on the turnaround strategy and foundry roadmap over the largely anticipated weak quarterly results.
• Closely monitor for any decision to pivot from the 18A to the 14A manufacturing node, as potential multi-billion dollar write-offs represent a material risk to the stock.
• Given the prevailing 'Hold' consensus and an average price target implying 6.82% downside, exercising caution is warranted until there is tangible evidence that the new CEO's turnaround plan is gaining traction.